Trump attacks study, defends using malaria drug for COVID-19
President Donald Trump attacked the validity of a study of veterans that raised alarms about the malaria drug he actively promotes as a treatment for the coronavirus
U.S. hospitals said they have pulled way back on the use of hydroxychloroquine, the malaria drug touted by President Donald Trump as a COVID-19 treatment, after several studies suggested it is not effective and may pose significant risks.
ZURICH (Reuters)—The World Health Organization (WHO) on Tuesday promised a swift review of data on hydroxychloroquine (HCQ), probably by mid-June, after safety concerns prompted the group to suspend the malaria drug’s use in a trial on COVID-19 patients. U.S. President Donald Trump and others have pushed HCQ as a possible coronavirus treatment, but the WHO... [Read More]
THURSDAY, May 28, 2020 -- As the evidence piles up that a malaria drug touted as a possible coronavirus treatment by President Donald Trump may instead harm patients, a new study shows the same might hold true for cancer patients with...
Exclusive:Australian researchers query origin of data used for Lancet study, but stress there is no evidence drug is a safe or effective treatment•Sign up for Guardian Australia ’s daily coronavirus email•Download the free Guardian app to get the most important news notificationsQuestions have been raised by Australian infectious disease researchers about a study published in the Lancet which prompted the World Health Organization to halt global trials of the drug hydroxychloroquine to treat Covid-19.Thestudy published on Friday found Covid-19 patients who received the malaria drug were dying at higher rate...
Nissan and Renault and trying to reset their troubled relationship. An E.U. recovery plan could bring the bloc closer to a shared budget.
[DW] African countries have imposed tough measures against COVID-19. But it may come at the cost of other untreated diseases such as malaria and AIDS.
WHO has urged Indonesia, one of the world's biggest advocates of two malaria drugs to treat the coronavirus, to suspend such treatment over safety concerns, a source familiar with the advice told Reuters on Tuesday.Reuters Health Information
France, Italy and Belgium acted to halt the use of hydroxychloroquine to treat patients suffering from COVID-19, the illness caused by the new coronavirus, amid questions about the safety of the generic anti-malaria drug.
France, Italy and Belgium acted to halt the use of hydroxychloroquine to treat patients suffering from COVID-19, the illness caused by the novel coronavirus, amid questions about the safety of the generic anti-malaria drug.
Researchers testArtemisia annua extracts against the novel coronavirus, while the WHO cautions that herbal remedies made from the plant could boost malaria resistance